Disrupting The Clinical Trial Enrollment Process

Clinical trial recruitment and enrollment is an area ripe for disruption. Clinical trials are responsible for approximately 40% of the overall pharmaceutical research budget in the United States – around $7 billion, and 40% of that is made up of costs associated with patient recruitment, totaling nearly $2 billion. Despite this huge expenditure, the recruitment process has been and, in many cases, continues to be inefficient.

Traditional recruitment models give sponsors little to no control over enrollment outcomes. With nearly half the budgets of clinical research already going toward recruitment, spending alone is not an answer. These models utilize mostly human-driven processes and are, as a result, widely inconsistent. It is common for sponsors to turn to multiple different recruitment strategies for a single trial in the hope that through attracting high volumes of interested candidates, they can reach their enrollment goals and timelines.

However, these broad strategies fall short in a few key ways. However, new technologies, grounded in the advanced use of data, have the opportunity to facilitate significant improvements to how patients are recruited for clinical trials.

To find out more about patient enrollment, visit the Clinical Leader Patient & Site Solutions Center.